Joel Hedgpeth
Director/Board Member at CompleGen, Inc.
Joel Hedgpeth active positions
Companies | Position | Start | End |
---|---|---|---|
CompleGen, Inc.
CompleGen, Inc. Pharmaceuticals: MajorHealth Technology CompleGen, Inc. provides HTS assays to the pharmaceutical, biopharmaceutical, and agchem industries. The company was founded by Joel Hedgpeth and John Swindle in 2000 and is headquartered in Seattle, WA. | Director/Board Member | 2012-03-05 | - |
Chairman | 1999-12-31 | 2012-03-25 | |
President | 1999-12-31 | 2012-03-25 |
Career history of Joel Hedgpeth
Former positions of Joel Hedgpeth
Companies | Position | Start | End |
---|---|---|---|
Epoch Biosciences, Inc.
Epoch Biosciences, Inc. Medical SpecialtiesHealth Technology Epoch Biosciences, Inc. manufactures and develops molecular tools for genetic analysis. Its technology has numerous applications including the detection of inherited diseases and single nucleotide polymorphisms to identify individuals at risk for disease or adverse drug reactions and gene expression measurement. The company was founded in 1985 and is headquartered in Bothell, WA. | Chief Operating Officer | - | 2001-12-31 |
Berlex Biosciences | Chief Operating Officer | - | 1992-12-31 |
Training of Joel Hedgpeth
The University of California, San Francisco | Undergraduate Degree |
Statistics
International
United States | 5 |
Operational
Chief Operating Officer | 2 |
Director/Board Member | 1 |
Chairman | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 3 |
---|---|
CompleGen, Inc.
CompleGen, Inc. Pharmaceuticals: MajorHealth Technology CompleGen, Inc. provides HTS assays to the pharmaceutical, biopharmaceutical, and agchem industries. The company was founded by Joel Hedgpeth and John Swindle in 2000 and is headquartered in Seattle, WA. | Health Technology |
Berlex Biosciences | |
Epoch Biosciences, Inc.
Epoch Biosciences, Inc. Medical SpecialtiesHealth Technology Epoch Biosciences, Inc. manufactures and develops molecular tools for genetic analysis. Its technology has numerous applications including the detection of inherited diseases and single nucleotide polymorphisms to identify individuals at risk for disease or adverse drug reactions and gene expression measurement. The company was founded in 1985 and is headquartered in Bothell, WA. | Health Technology |
- Stock Market
- Insiders
- Joel Hedgpeth
- Experience